{
    "organizations": [],
    "uuid": "d91d2d347c810ec563027dc59a7f78a15647b032",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bristol-myers-squibb-collaborates/brief-bristol-myers-squibb-collaborates-with-janssen-to-develop-commercialize-factor-xia-inhibitors-idUSB8N1KT00R",
    "ord_in_thread": 0,
    "title": "Bristol-Myers Squibb Collaborates With Janssen To Develop & Commercialize Factor XIa Inhibitors",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - Bristol-Myers Squibb Co:\n* BRISTOL-MYERS SQUIBB ANNOUNCES WORLDWIDE COLLABORATION WITH JANSSEN TO DEVELOP & COMMERCIALIZE BRISTOL-MYERSâ€™ FACTOR XIA INHIBITOR, BMS-986177\n* BRISTOL-MYERS SQUIBB SAYS JANSSEN WILL PAY CO UPFRONT SUM ALONG WITH POTENTIAL DEVELOPMENT & REGULATORY MILESTONE PAYMENTS\n* BRISTOL-MYERS SQUIBB SAYS CO, JANSSEN EXPECTED TO ADVANCE BMS-986177 INTO PHASE 2 CLINICAL TRIALS IN H2 2018 FOR STUDY OF SECONDARY STROKE PREVENTION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-17T05:12:00.000+03:00",
    "crawled": "2018-04-17T00:20:33.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "squibb",
        "co",
        "squibb",
        "announces",
        "worldwide",
        "collaboration",
        "janssen",
        "develop",
        "commercialize",
        "factor",
        "xia",
        "inhibitor",
        "squibb",
        "say",
        "janssen",
        "pay",
        "co",
        "upfront",
        "sum",
        "along",
        "potential",
        "development",
        "regulatory",
        "milestone",
        "payment",
        "squibb",
        "say",
        "co",
        "janssen",
        "expected",
        "advance",
        "phase",
        "clinical",
        "trial",
        "h2",
        "study",
        "secondary",
        "stroke",
        "prevention",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}